356 related articles for article (PubMed ID: 28743636)
1. Valproate increases dopamine transporter expression through histone acetylation and enhanced promoter binding of Nurr1.
Green AL; Zhan L; Eid A; Zarbl H; Guo GL; Richardson JR
Neuropharmacology; 2017 Oct; 125():189-196. PubMed ID: 28743636
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic regulation contributes to urocortin-enhanced midbrain dopaminergic neuron differentiation.
Huang HY; Chiu TL; Chang HF; Hsu HR; Pang CY; Liew HK; Wang MJ
Stem Cells; 2015 May; 33(5):1601-17. PubMed ID: 25641682
[TBL] [Abstract][Full Text] [Related]
3. Troglitazone inhibits histone deacetylase activity in breast cancer cells.
Davies GF; Ross AR; Arnason TG; Juurlink BH; Harkness TA
Cancer Lett; 2010 Feb; 288(2):236-50. PubMed ID: 19699029
[TBL] [Abstract][Full Text] [Related]
4. Trichostatin A induces 5-lipoxygenase promoter activity and mRNA expression via inhibition of histone deacetylase 2 and 3.
Pufahl L; Katryniok C; Schnur N; Sorg BL; Metzner J; Grez M; Steinhilber D
J Cell Mol Med; 2012 Jul; 16(7):1461-73. PubMed ID: 21883892
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic mechanisms in the dopamine D2 receptor-dependent inhibition of the prolactin gene.
Liu JC; Baker RE; Chow W; Sun CK; Elsholtz HP
Mol Endocrinol; 2005 Jul; 19(7):1904-17. PubMed ID: 15731170
[TBL] [Abstract][Full Text] [Related]
6. Histone hyperacetylation up-regulates protein kinase Cδ in dopaminergic neurons to induce cell death: relevance to epigenetic mechanisms of neurodegeneration in Parkinson disease.
Jin H; Kanthasamy A; Harischandra DS; Kondru N; Ghosh A; Panicker N; Anantharam V; Rana A; Kanthasamy AG
J Biol Chem; 2014 Dec; 289(50):34743-67. PubMed ID: 25342743
[TBL] [Abstract][Full Text] [Related]
7. Lysine deacetylase inhibition attenuates hypertension and is accompanied by acetylation of mineralocorticoid receptor instead of histone acetylation in spontaneously hypertensive rats.
Seok YM; Lee HA; Park KM; Hwangbo MH; Kim IK
Naunyn Schmiedebergs Arch Pharmacol; 2016 Jul; 389(7):799-808. PubMed ID: 27106211
[TBL] [Abstract][Full Text] [Related]
8. HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes.
Ooi JY; Tuano NK; Rafehi H; Gao XM; Ziemann M; Du XJ; El-Osta A
Epigenetics; 2015; 10(5):418-30. PubMed ID: 25941940
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism.
Farrajota K; Cheng S; Martel-Pelletier J; Afif H; Pelletier JP; Li X; Ranger P; Fahmi H
Arthritis Rheum; 2005 Jan; 52(1):94-104. PubMed ID: 15641079
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic Regulation of Dopamine Transporter mRNA Expression in Human Neuroblastoma Cells.
Green AL; Hossain MM; Tee SC; Zarbl H; Guo GL; Richardson JR
Neurochem Res; 2015 Jul; 40(7):1372-8. PubMed ID: 25963949
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of histone deacetylases by Trichostatin A leads to a HoxB4-independent increase of hematopoietic progenitor/stem cell frequencies as a result of selective survival.
Obier N; Uhlemann CF; Müller AM
Cytotherapy; 2010 Nov; 12(7):899-908. PubMed ID: 20210674
[TBL] [Abstract][Full Text] [Related]
12. Pitx3 potentiates Nurr1 in dopamine neuron terminal differentiation through release of SMRT-mediated repression.
Jacobs FM; van Erp S; van der Linden AJ; von Oerthel L; Burbach JP; Smidt MP
Development; 2009 Feb; 136(4):531-40. PubMed ID: 19144721
[TBL] [Abstract][Full Text] [Related]
13. The role of histone acetylation in SMN gene expression.
Kernochan LE; Russo ML; Woodling NS; Huynh TN; Avila AM; Fischbeck KH; Sumner CJ
Hum Mol Genet; 2005 May; 14(9):1171-82. PubMed ID: 15772088
[TBL] [Abstract][Full Text] [Related]
14. PSG gene expression is up-regulated by lysine acetylation involving histone and nonhistone proteins.
Camolotto SA; Racca AC; Ridano ME; Genti-Raimondi S; Panzetta-Dutari GM
PLoS One; 2013; 8(2):e55992. PubMed ID: 23418492
[TBL] [Abstract][Full Text] [Related]
15. Re-Cloning the N27 Dopamine Cell Line to Improve a Cell Culture Model of Parkinson's Disease.
Gao L; Zhou W; Symmes B; Freed CR
PLoS One; 2016; 11(8):e0160847. PubMed ID: 27512998
[TBL] [Abstract][Full Text] [Related]
16. Prolonged membrane depolarization enhances midbrain dopamine neuron differentiation via epigenetic histone modifications.
He XB; Yi SH; Rhee YH; Kim H; Han YM; Lee SH; Lee H; Park CH; Lee YS; Richardson E; Kim BW; Lee SH
Stem Cells; 2011 Nov; 29(11):1861-73. PubMed ID: 21922608
[TBL] [Abstract][Full Text] [Related]
17. Regulation of intestinal serotonin transporter expression via epigenetic mechanisms: role of HDAC2.
Gill RK; Kumar A; Malhotra P; Maher D; Singh V; Dudeja PK; Alrefai W; Saksena S
Am J Physiol Cell Physiol; 2013 Feb; 304(4):C334-41. PubMed ID: 23195070
[TBL] [Abstract][Full Text] [Related]
18. Targeting AML1/ETO-histone deacetylase repressor complex: a novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1/ETO-positive acute myeloid leukemia cells.
Liu S; Klisovic RB; Vukosavljevic T; Yu J; Paschka P; Huynh L; Pang J; Neviani P; Liu Z; Blum W; Chan KK; Perrotti D; Marcucci G
J Pharmacol Exp Ther; 2007 Jun; 321(3):953-60. PubMed ID: 17389244
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic evidence of an Ac/Dc axis by VPA and SAHA.
Lunke S; Maxwell S; Khurana I; K N H; Okabe J; Al-Hasani K; El-Osta A
Clin Epigenetics; 2021 Mar; 13(1):58. PubMed ID: 33743782
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide screening for target regions of histone deacetylases in cardiomyocytes.
Kaneda R; Ueno S; Yamashita Y; Choi YL; Koinuma K; Takada S; Wada T; Shimada K; Mano H
Circ Res; 2005 Aug; 97(3):210-8. PubMed ID: 16002748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]